115 related articles for article (PubMed ID: 671172)
1. Plasma levels, half-life values, and correlation with physiologic assays for growth and immunity.
Green OC; Winter RJ; Kawahara FS; Phillips LS; Lewy PR; Hart RL; Pachman LM
J Pediatr; 1978 Aug; 93(2):299-303. PubMed ID: 671172
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous determination of prednisolone, prednisone, cortisol, and cortisone in plasma by GC-MS: estimating unbound prednisolone concentration in patients with nephrotic syndrome during oral prednisolone therapy.
Shibasaki H; Nakayama H; Furuta T; Kasuya Y; Tsuchiya M; Soejima A; Yamada A; Nagasawa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):164-9. PubMed ID: 18387858
[TBL] [Abstract][Full Text] [Related]
3. Effect on nephrotic syndrome on absorption and disposition of prednisolone in children.
Rocci ML; Assael BM; Appiani AC; Edefonti A; Jusko WJ
Int J Pediatr Nephrol; 1982 Sep; 3(3):159-66. PubMed ID: 7141787
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of prednisolone in children with the nephrotic syndrome.
Rostin M; Barthe P; Houin G; Alvinerie M; Bouissou F
Pediatr Nephrol; 1990 Sep; 4(5):470-3. PubMed ID: 2242307
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of prednisone and its metabolite prednisolone in children with nephrotic syndrome during the active phase and in remission.
Gatti G; Perucca E; Frigo GM; Notarangelo LD; Barberis L; Martini A
Br J Clin Pharmacol; 1984 Apr; 17(4):423-31. PubMed ID: 6721988
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and protein binding of prednisolone in patients with nephrotic syndrome and patients undergoing hemodialysis.
Bergrem H
Kidney Int; 1983 Jun; 23(6):876-81. PubMed ID: 6887699
[No Abstract] [Full Text] [Related]
7. Prednisone or prednisolone for the treatment of chronic active hepatitis? A comparison of plasma availability.
Davis M; Williams R; Chakraborty J; English J; Marks V; Ideo G; Tempini S
Br J Clin Pharmacol; 1978 Jun; 5(6):501-5. PubMed ID: 656293
[TBL] [Abstract][Full Text] [Related]
8. Prednisolone pulse therapy for childhood systemic lupus erythematosus with prominent dermatomyositis. A case report.
Wollina U; Schreiber G
Dermatologica; 1985; 171(1):45-8. PubMed ID: 4029461
[TBL] [Abstract][Full Text] [Related]
9. [Removal of prednisone and prednisolone during plasma exchange].
Assogba U; Baumelou A; Pecquinot MA; Raymond F; Durande JP; Lenoir G; Rottembourg J
Ann Med Interne (Paris); 1988; 139 Suppl 1():38-9. PubMed ID: 3247989
[TBL] [Abstract][Full Text] [Related]
10. Posterior subcapsular cataracts. Related to long-term corticosteroid treatment in children.
Bihari M; Grossman BJ
Am J Dis Child; 1968 Dec; 116(6):604-8. PubMed ID: 5697192
[No Abstract] [Full Text] [Related]
11. The pharmacokinetics of plasma total and free prednisolone during an alternate-day regimen.
Fuwa Y; Yasuda K; Adachi K; Goshima E; Yamakita N; Miura K
Nihon Naibunpi Gakkai Zasshi; 1991 Jan; 67(1):8-22. PubMed ID: 2013347
[TBL] [Abstract][Full Text] [Related]
12. Influence of body condition on plasma prednisolone and prednisone concentrations in clinically healthy cats after single oral dose administration.
Center SA; Randolph JF; Warner KL; Simpson KW; Rishniw M
Res Vet Sci; 2013 Aug; 95(1):225-30. PubMed ID: 23473553
[TBL] [Abstract][Full Text] [Related]
13. Randomized Trial of Dexamethasone Versus Prednisone for Children with Acute Asthma Exacerbations.
Paniagua N; Lopez R; Muñoz N; Tames M; Mojica E; Arana-Arri E; Mintegi S; Benito J
J Pediatr; 2017 Dec; 191():190-196.e1. PubMed ID: 29173304
[TBL] [Abstract][Full Text] [Related]
14. Measurement of plasma prednisolone in man.
Wilson CG; Ssendagire R; May CS; Paterson JW
Br J Clin Pharmacol; 1975 Aug; 2(4):321-5. PubMed ID: 1233991
[TBL] [Abstract][Full Text] [Related]
15. The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone.
Frey FJ; Rüegsegger MK; Frey BM
Br J Clin Pharmacol; 1986 Feb; 21(2):183-9. PubMed ID: 3954934
[TBL] [Abstract][Full Text] [Related]
16. Plasma prednisolone levels and adrenocortical responsiveness after administration of prednisolone-21-phosphate as a retention enema.
Lee DA; Taylor GM; James VH; Walker G
Gut; 1979 May; 20(5):349-55. PubMed ID: 223947
[TBL] [Abstract][Full Text] [Related]
17. Prednisone and prednisolone bioavailability in renal transplant patients.
Gambertoglio JG; Frey FJ; Holford NH; Birnbaum JL; Lizak PS; Vincenti F; Feduska NJ; Salvatierra O; Amend WJ
Kidney Int; 1982 Apr; 21(4):621-6. PubMed ID: 7047863
[TBL] [Abstract][Full Text] [Related]
18. Removal of prednisone and prednisolone by plasma exchange.
Stigelman WH; Henry DH; Talbert RL; Townsend RJ
Clin Pharm; 1984; 3(4):402-7. PubMed ID: 6467876
[TBL] [Abstract][Full Text] [Related]
19. Follow-up of linear growth of body height in children with nephrotic syndrome.
Hung YT; Yang LY
J Microbiol Immunol Infect; 2006 Oct; 39(5):422-5. PubMed ID: 17066206
[TBL] [Abstract][Full Text] [Related]
20. High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma.
Schuh S; Dick PT; Stephens D; Hartley M; Khaikin S; Rodrigues L; Coates AL
Pediatrics; 2006 Aug; 118(2):644-50. PubMed ID: 16882819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]